1. Home
  2. JELD vs NPCE Comparison

JELD vs NPCE Comparison

Compare JELD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JELD
  • NPCE
  • Stock Information
  • Founded
  • JELD 1960
  • NPCE 1997
  • Country
  • JELD United States
  • NPCE United States
  • Employees
  • JELD N/A
  • NPCE N/A
  • Industry
  • JELD Forest Products
  • NPCE Medical Specialities
  • Sector
  • JELD Basic Materials
  • NPCE Health Care
  • Exchange
  • JELD Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • JELD 383.8M
  • NPCE 312.2M
  • IPO Year
  • JELD 2017
  • NPCE 2021
  • Fundamental
  • Price
  • JELD $4.54
  • NPCE $8.99
  • Analyst Decision
  • JELD Hold
  • NPCE Strong Buy
  • Analyst Count
  • JELD 8
  • NPCE 6
  • Target Price
  • JELD $7.34
  • NPCE $16.33
  • AVG Volume (30 Days)
  • JELD 1.4M
  • NPCE 209.9K
  • Earning Date
  • JELD 08-05-2025
  • NPCE 08-12-2025
  • Dividend Yield
  • JELD N/A
  • NPCE N/A
  • EPS Growth
  • JELD N/A
  • NPCE N/A
  • EPS
  • JELD N/A
  • NPCE N/A
  • Revenue
  • JELD $3,592,472,000.00
  • NPCE $84,306,000.00
  • Revenue This Year
  • JELD N/A
  • NPCE $21.04
  • Revenue Next Year
  • JELD $3.46
  • NPCE $10.73
  • P/E Ratio
  • JELD N/A
  • NPCE N/A
  • Revenue Growth
  • JELD N/A
  • NPCE 22.05
  • 52 Week Low
  • JELD $3.27
  • NPCE $5.45
  • 52 Week High
  • JELD $16.81
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • JELD 50.83
  • NPCE 38.09
  • Support Level
  • JELD $4.93
  • NPCE $8.59
  • Resistance Level
  • JELD $5.25
  • NPCE $9.09
  • Average True Range (ATR)
  • JELD 0.27
  • NPCE 0.39
  • MACD
  • JELD -0.02
  • NPCE 0.05
  • Stochastic Oscillator
  • JELD 39.06
  • NPCE 54.41

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: